Confirmed Supporters

• Confirmed Sponsors
• Confirmed Exhibitors
• Live Floorplan

Confirmed Sponsors

ICNMD 2020 would like to thank the following companies for their generous support:

	Sarepta

	Pharnext
Takeda

Confirmed Exhibitors

	Alexion Pharma GmbH | Booth #9-10 (alexion.com)
	Audentes Therapeutics | Booth #21 (audentestx.com)
	AveXis, Inc. | Booth #23 AveXis is a gene therapy company focused on developing novel treatments and ensuring access for patients and families affected by rare and life-threatening neurological genetic diseases. Our goal is to utilise cutting-edge science to deliver a functional copy of a lost or defective gene, using a single-dose delivery method. (avexis.com)
	Cadwell Industries, Inc. | Booth #12 For 40 years Cadwell has combined customer insight, employee expertise, and cutting-edge innovation to deliver, and support our products with the goals of delighting our customers and improving the lives of patients. Sierra Summit seamlessly integrates EMG or NCS with neuromuscular ultrasound into a single procedure with a common user interface. (cadwell.com)
	Pharnext | Booth #14 (pharnext.com)
	Roche | Booth #15-18 Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. (roche.com)
	Sanofi Genzyme | Booth #20-22 Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families. (sanofigenzyme.com)
	Santhera | Booth #19 Santhera Pharmaceuticals (SIX: SANN) focuses on developing innovative medicines for rare neuromuscular and pulmonary diseases. In Europe, Puldysa® (idebenone) is under regulatory review by the EMA for Duchenne muscular dystrophy. The pipeline includes rights to dissociative steroid vamorolone for DMD, POL6014 for cystic fibrosis and omigapil for congenital muscular dystrophy. (santhera.com)
	Sarepta Therapeutics | Booth #2 (sarepta.com)
	Takeda | Booth #11 (takeda.com)

Live Floorplan

Housing Piracy Scam

WARNING: We are aware that illegitimate companies are targeting our sponsors and exhibitors, calling to ‘offer’ to set you up with accommodation. These companies are often fraudulent. Please note that they are not affiliated with us and that the only way to register & book accommodation will be only through the Congress website (coming soon).